The UK peptide therapeutics market will see a considerable growth of 3.7% during the forecast period. Well established healthcare infrastructure is also one of the key reasons which are expected to promote the acceptance of peptide therapeutics in the UK for the treatment of various health conditions, such as CVD, cancer, and others. The market players in the UK are focusing on the integration of novel technologies, to enhance the treatment of peptide therapeutics in the country.
- Spotlight on liquid chromatography key techniques for peptide purification and applications for development and commercial peptides.
- Strategies for peptide half-life extension including updating the GLP-1 field and techniques on improving the delivery of peptides.
- Achieving peptide optimization by improving physical and chemical stability, permeability, and bioavailability.
A full report of UK Peptide Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/uk-peptide-therapeutics-market
The significant prevalence of cancer and respiratory disorders in the UK has led the players to invest in the R&D of new technologies to promote the effective treatment of cancer across the country. For instance, in February 2020, Genentech in partnership with Bicycle Therapeutics entered a drug discovery in cancer research for the clinical-stage biotech. Bicycle Therapeutics is a Cambridge based company, developing a new class of drugs comprised of peptides, which are chains of amino acids. The partnership covers up to 4 drugs that are used to treat multiple immuno-oncology targets.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-peptide-therapeutics-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Route of Administration and By Application
- Key Companies Profiled- Novo Nordisk A/S, AstraZeneca Plc, GlaxoSmithKline PLC, Sanofi SA, and Novartis International AG
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
UK Peptide Therapeutics Market – Segmentation
By Route of Administration
- Oral
- Parenteral
By Application
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
